Alzheimer's disease [[electronic resource] ] : advances in etiology, pathogenesis and therapeutics / / edited by Khalid Iqbal, Sangram S. Sisodia, Bengt Winblad |
Pubbl/distr/stampa | Chichester ; ; New York, : Wiley, c2001 |
Descrizione fisica | 1 online resource (890 p.) |
Disciplina | 616.831 |
Altri autori (Persone) |
IqbalKhalid
SisodiaSangram S WinbladBengt |
Soggetto topico | Alzheimer's disease |
ISBN |
1-280-10126-1
9786610101269 0-470-85174-0 0-470-84645-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Alzheimer's Disease ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS; Contents; List of Contributors; Dedications; Scientists Honored for Pioneering Research; Preface; Acknowledgments; I. EPIDEMIOLOGY AND RISK FACTORS; 1. The Transition from Normal Functioning to Dementia in the Aging Population; 2. Epidemiology of Alzheimer's Disease and Dementia: Advances and Challenges; 3. Epidemiology of Dementia in Down's Syndrome; II. GENETICS; 4. A Genomic Search for Alzheimer's Disease Genes
5. Candidate Genes Showing No Evidence of Association with Alzheimer's Disease: Results of the NIMH-AD Genetics Initiative6. Familial Alzheimer's Disease with Spastic Paraparesis Associated with a Mutation at Codon 261 of the Presenilin 1 Gene; 7. Genetic Analysis of the Presenilin Pathway in Drosophila; 8. Molecular Genetics and Transgenic Modeling of the Tauopathies; 9. Regulation of Four-repeat tau Expression: Interactions between Exon and Intron Splicing Regulatory Sequences; III. DIAGNOSIS AND CLINICAL COURSE 10. Preclinical Prediction of AD: Relation Between Neuropsychological and Neuroimaging Findings11. Neuropsychological Detection of Preclinical Alzheimer's Disease: Results of a Neuropathological Series of 'Normal' Controls; 12. Potentially Reversible Conditions in Memory Clinic Patients; 13. The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials; 14. Mild Cognitive Impairment: Transition from Aging to Alzheimer's Disease; 15. Brain Functional Imaging in Early and Preclinical Alzheimer's Disease 16. Amyloid, PHF-tau, Ubiquitin and Synaptic Markers in the Progression of Alzheimer's Disease: Immunochemical Analyses of Frontal Cortex from Prospectively Studied Elderly Humans17. Imaging the Consequences of Alzheimer's Disease Pathology; 18. Influence of apoE Genotype and PET Brain Imaging on Preclinical Prediction of Alzheimer's Disease; 19. Overview of Vascular Dementia; 20. Clinical and Imaging Characteristics of Vascular Dementia in a Memory Clinic; 21. MRI of Entorhinal Cortex and Hippocampus in Alzheimer's Disease, Subcortical Ischemic Vascular Dementia and Mixed Dementia 22. Olfactory Function and Event-related Potentials in Alzheimer's Disease23. Phenotypic Differences in Cholinergic Markers within the Nucleus Basalis in Individuals with Mild Cognitive Impairment; 24. Evaluating CNS Biomarkers for Alzheimer's Disease; 25. CSF Markers for Early Alzheimer's Disease; 26. CSF-Phospho-tau (181P) as a Promising Marker for Discriminating Alzheimer's Disease from Dementia with Lewy Bodies; 27. Increased Levels of a Minor Glycoform of Acetylcholinesterase in Alzheimer's Disease Brain and Cerebrospinal Fluid 28. Plasma b-Amyloid as a Surrogate Genetic Marker in Late-onset Alzheimer's Disease |
Record Nr. | UNINA-9910142491603321 |
Chichester ; ; New York, : Wiley, c2001 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Alzheimer's disease [[electronic resource] ] : advances in etiology, pathogenesis and therapeutics / / edited by Khalid Iqbal, Sangram S. Sisodia, Bengt Winblad |
Pubbl/distr/stampa | Chichester ; ; New York, : Wiley, c2001 |
Descrizione fisica | 1 online resource (890 p.) |
Disciplina | 616.831 |
Altri autori (Persone) |
IqbalKhalid
SisodiaSangram S WinbladBengt |
Collana |
Fact sheet
NIH publication |
Soggetto topico | Alzheimer's disease |
Soggetto genere / forma |
Online resources.
Popular works. |
ISBN |
1-280-10126-1
9786610101269 0-470-85174-0 0-470-84645-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Alzheimer's Disease ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS; Contents; List of Contributors; Dedications; Scientists Honored for Pioneering Research; Preface; Acknowledgments; I. EPIDEMIOLOGY AND RISK FACTORS; 1. The Transition from Normal Functioning to Dementia in the Aging Population; 2. Epidemiology of Alzheimer's Disease and Dementia: Advances and Challenges; 3. Epidemiology of Dementia in Down's Syndrome; II. GENETICS; 4. A Genomic Search for Alzheimer's Disease Genes
5. Candidate Genes Showing No Evidence of Association with Alzheimer's Disease: Results of the NIMH-AD Genetics Initiative6. Familial Alzheimer's Disease with Spastic Paraparesis Associated with a Mutation at Codon 261 of the Presenilin 1 Gene; 7. Genetic Analysis of the Presenilin Pathway in Drosophila; 8. Molecular Genetics and Transgenic Modeling of the Tauopathies; 9. Regulation of Four-repeat tau Expression: Interactions between Exon and Intron Splicing Regulatory Sequences; III. DIAGNOSIS AND CLINICAL COURSE 10. Preclinical Prediction of AD: Relation Between Neuropsychological and Neuroimaging Findings11. Neuropsychological Detection of Preclinical Alzheimer's Disease: Results of a Neuropathological Series of 'Normal' Controls; 12. Potentially Reversible Conditions in Memory Clinic Patients; 13. The Alzheimer's Disease Centers' Neuropsychological Database Initiative: A Resource for Alzheimer's Disease Prevention Trials; 14. Mild Cognitive Impairment: Transition from Aging to Alzheimer's Disease; 15. Brain Functional Imaging in Early and Preclinical Alzheimer's Disease 16. Amyloid, PHF-tau, Ubiquitin and Synaptic Markers in the Progression of Alzheimer's Disease: Immunochemical Analyses of Frontal Cortex from Prospectively Studied Elderly Humans17. Imaging the Consequences of Alzheimer's Disease Pathology; 18. Influence of apoE Genotype and PET Brain Imaging on Preclinical Prediction of Alzheimer's Disease; 19. Overview of Vascular Dementia; 20. Clinical and Imaging Characteristics of Vascular Dementia in a Memory Clinic; 21. MRI of Entorhinal Cortex and Hippocampus in Alzheimer's Disease, Subcortical Ischemic Vascular Dementia and Mixed Dementia 22. Olfactory Function and Event-related Potentials in Alzheimer's Disease23. Phenotypic Differences in Cholinergic Markers within the Nucleus Basalis in Individuals with Mild Cognitive Impairment; 24. Evaluating CNS Biomarkers for Alzheimer's Disease; 25. CSF Markers for Early Alzheimer's Disease; 26. CSF-Phospho-tau (181P) as a Promising Marker for Discriminating Alzheimer's Disease from Dementia with Lewy Bodies; 27. Increased Levels of a Minor Glycoform of Acetylcholinesterase in Alzheimer's Disease Brain and Cerebrospinal Fluid 28. Plasma b-Amyloid as a Surrogate Genetic Marker in Late-onset Alzheimer's Disease |
Record Nr. | UNINA-9910678020603321 |
Chichester ; ; New York, : Wiley, c2001 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Severe dementia / / editors, Alistair Burns, Bengt Winblad |
Pubbl/distr/stampa | Chichester, West Sussex, England ; ; Hoboken, NJ, : John Wiley & Sons, c2006 |
Descrizione fisica | 1 online resource (262 p.) |
Disciplina |
616.83
616.831061 |
Altri autori (Persone) |
BurnsAlistair S
WinbladBengt |
Soggetto topico |
Dementia
Dementia - Chemotherapy Dementia - Treatment |
ISBN |
1-280-45054-1
9786610450541 0-470-01056-8 0-470-01055-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Severe Dementia; Contents; List of Contributors; Introduction; Part 1 Introductory; Chapter 1 Assessment and Diagnosis of Severe Dementia; Chapter 2 Cholinergic and Serotonergic Systems in Severe Dementia; Chapter 3 The Molecular Pathology of Severe Dementia; Part 2 Clinical Features of Severe Dementia; Chapter 4 Cognitive Functions in Severe Dementia; Chapter 5 Behavioural and Psychological Symptoms of Dementia - Agitation; Chapter 6 Depression in Severe Dementia; Chapter 7 Physical Aspects of Severe Alzheimer's Disease; Chapter 8 Clinical Features of Severe Dementia: Staging
Chapter 9 Clinical Features of Severe Dementia: FunctionPart 3 Management; Chapter 10 Drug Treatment: Memantine; Chapter 11 Drug Treatment: Cholinesterase Inhibitors; Chapter 12 Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics; Chapter 13 Non-pharmacological Treatment of Severe Dementia: An Overview; Chapter 14 Non-pharmacological Treatment of Severe Dementia:the Seattle Protocols; Chapter 15 Care by Families for Late Stage Dementia; Chapter 16 Person-centred Care for People with Severe Dementia Chapter 17 Palliative Care in Patients with Severe DementiaChapter 18 Narrative Ethics and Ethical Narratives in Dementia; Chapter 19 Health Economics of Severe Dementia; Index |
Record Nr. | UNINA-9910143686403321 |
Chichester, West Sussex, England ; ; Hoboken, NJ, : John Wiley & Sons, c2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Severe dementia / / editors, Alistair Burns, Bengt Winblad |
Pubbl/distr/stampa | Chichester, West Sussex, England ; ; Hoboken, NJ, : John Wiley & Sons, c2006 |
Descrizione fisica | 1 online resource (262 p.) |
Disciplina |
616.83
616.831061 |
Altri autori (Persone) |
BurnsAlistair S
WinbladBengt |
Soggetto topico |
Dementia
Dementia - Chemotherapy Dementia - Treatment |
ISBN |
1-280-45054-1
9786610450541 0-470-01056-8 0-470-01055-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Severe Dementia; Contents; List of Contributors; Introduction; Part 1 Introductory; Chapter 1 Assessment and Diagnosis of Severe Dementia; Chapter 2 Cholinergic and Serotonergic Systems in Severe Dementia; Chapter 3 The Molecular Pathology of Severe Dementia; Part 2 Clinical Features of Severe Dementia; Chapter 4 Cognitive Functions in Severe Dementia; Chapter 5 Behavioural and Psychological Symptoms of Dementia - Agitation; Chapter 6 Depression in Severe Dementia; Chapter 7 Physical Aspects of Severe Alzheimer's Disease; Chapter 8 Clinical Features of Severe Dementia: Staging
Chapter 9 Clinical Features of Severe Dementia: FunctionPart 3 Management; Chapter 10 Drug Treatment: Memantine; Chapter 11 Drug Treatment: Cholinesterase Inhibitors; Chapter 12 Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics; Chapter 13 Non-pharmacological Treatment of Severe Dementia: An Overview; Chapter 14 Non-pharmacological Treatment of Severe Dementia:the Seattle Protocols; Chapter 15 Care by Families for Late Stage Dementia; Chapter 16 Person-centred Care for People with Severe Dementia Chapter 17 Palliative Care in Patients with Severe DementiaChapter 18 Narrative Ethics and Ethical Narratives in Dementia; Chapter 19 Health Economics of Severe Dementia; Index |
Record Nr. | UNINA-9910830573203321 |
Chichester, West Sussex, England ; ; Hoboken, NJ, : John Wiley & Sons, c2006 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|